Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases

Journal of Alzheimer's Disease

Volumn 9, Issue SUPPL. 3, 2006, Pages 35-44

  Braak, Heiko ^a,b   Rüb, Udo ^a   Schultz, Christian ^a   Del Tredici, Kelly ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Institute fur Clinical Neuroanatomy   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; BRAIN CORTEX; DEGENERATIVE DISEASE; DISEASE COURSE; HUMAN; LIMBIC SYSTEM; MYELINATION; NEOCORTEX; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 33747432277     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2006-9s305     Document Type: Review

References (50)

1. J.E. Ahlskog, Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease, Mov. Disord. 20 (2005), 271-282.
2. H. Apaydin, E. Ahlskog, J.E. Parisi, B.F. Boeve and D.W. Dickson, Parkinson disease neuropathology, Arch. Neurol. 59 (2002), 102-112.
3. T. Arendt, M.K. Brückner, H.J. Gertz and L. Marcova, Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain, Neuroscience 83 (1998), 991-1002.
4. S.E. Arnold, B.T. Hyman, J. Flory, A.R. Damasio and G.W. van Hoesen, The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease, Cerebral Cortex 1 (1991), 103-116.
5. J. Bachevalier and M. Mishkin, Ontogenetic development and decline of memory functions in nonhuman primates, in: Neurodevelopment. Aging and Cognition, I. Kostovic, S. Knezevic, H.M. Wisniewski and G.J. Spillich, eds, Birkhäuser, Boston, 1992, pp. 37-59.
6. G. Bartzokis, J.L. Cummings, D. Sultzer, V. Henderson, K.H. Nuechterlein and J. Mintz, White matter structural integrity in healthy aging adults and patients with Alzheimer's disease, Arch. Neurol. 60 (2003), 393-398.
7. M.F. Beal, Aging, energy, and oxidative stress in neurodegenerative diseases, Ann. Neurol. 38 (1995), 357-366.
8. E. Braak, H. Braak and E.M. Mandelkow, A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads, Acta Neuropathol. 87 (1994), 554-567.
9. H. Braak, Architectonics of the Human Telencephalic Cortex, Springer, Berlin, 1980.
10. H. Braak, Architectonics as seen by lipofuscin stains, in: Cerebral Cortex, (Vol. 1), E.G. Jones and A. Peters, eds, Plenum, New York, 1984, pp. 59-104.
11. H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol. 82 (1991), 239-259.
12. H. Braak and E. Braak, Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis, Acta Neuropathol. 92(1996), 197-201.
13. H. Braak and E. Braak, Temporal sequence of Alzheimer's disease-related pathology, in: Cerebral Cortex, (Vol. 14), A. Peters and J.H. Morrison, eds, Plenum, New York, 1999, pp. 475-512.
14. H. Braak, R.A.I, de Vos, E.N.H. Jansen, H. Bratzke and E. Braak, Neuropathological hallmarks of Alzheimer's and Parkinson's diseases, Prog. Brain Res. 117 (1998), 267-285.
15. H. Braak, K. Del Tredici, C. Schultz and E. Braak, Vulnerability of select neuronal types to Alzheimer's disease, Ann N.Y. Acad. Sci. 924 (2000), 53-61.
16. H. Braak, K. Del Tredici, U. Rub, R.A.I, de Vos, E.N.H. Jansen Steur and E. Braak†, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol. Aging 24 (2003), 197-210.
17. H. Braak, E. Ghebremedhin, U. Rüb, H. Bratzke and K. Del Tredici, Stages in the development of Parkinson's disease-related pathology, Cell Tissue Res. 318 (2004), 121-134.
18. S.T. Brady, A.S. Witt, L.L. Kirkpatrick, S.M. de Waegh, C. Readhead, P.H. Tu and V.M.Y. Lee, Formation of compact myelin is required for maturation of the axonal cytoskeleton, J. Neurosci. 19 (1999), 7278-7288.
19. U.T. Brunk and A. Terman, Lipofuscin: mechanisms of age-related accumulation and influence on cell function, Free Radical Biol. Med. 33 (2002), 611-619.
20. K. Del Tredici and H. Braak, Idiopathic Parkinson's disease: staging an α-synucleinopathy with a predictable pathoanatomy, in: Molecular Basis of Parkinson's Disease, P. Kahle and C. Haass, eds, Landes Bioscience, Georgetown, TX, 2003, pp. 1-32.
21. D.W. Dickson, Tau and synuclein and their role in neuropathology, Brain Pathol. 9 (1999), 657-661.
22. D.B. Fonseca, M.R.J. Sheehy, N. Blackman, P.M.J. Shelton and A.E. Prior, Reversal of a hallmark of brain ageing: lipofuscin accumulation, Neurobiol. Aging 26 (2005), 69-76.
23. B.I. Giasson, J.E. Galvin, V.M.-Y. Lee and J.Q. Trojanowski, The cellular and molecular pathology of Parkinson's disease, in: Neurodegenerative Dementias: Clinical Features and Pathological Mechanisms, C.M. Clark and J.Q. Trojanowski, eds, McGraw Hill, New York, 2000, pp. 219-228.
24. M. Goedert and M.G. Spillantini, Tauopathies and α- synucleinopathies, in: Fatal Attractions: Protein Aggregates in Neurodegenerative Disorders, V.M.Y. Lee, J.Q. Trojanowski, L. Buée and Y. Christen, eds, Springer, Berlin, 2000, pp. 66-86.
25. D.A. Gray and J. Woulfe, Lipofuscin and aging: a matter of toxic waste, Sci. Aging Knowledge Environ. 2 (2005), 1-5.
26. C. Hildebrand, S. Remahl, H. Persson and C. Bjartmar, Myelinated nerve fibres in the CNS, Prog. Neurobiol. 40 (1993), 319-384.
27. P.R. Hof, K. Cox, W.G. Young, M.R. Celio, J. Rogers and J.H. Morrison, Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease, J. Neuropathol. Exp. Neurol. 50 (1991), 451-462.
28. P.R. Hof, E.A. Nimchinsky, M.R. Celio, C. Bouras and J.H. Morrison, Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease, Neurosci. Lett. 152 (1993), 145-149.
29. B.T. Hyman and T. Goméz-Isla, Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease, Neurobiol. Aging 15 (1994), 353-354.
30. P. Jenner, Oxidative stress in Parkinson's disease, Ann. Neurol. 53(suppl. 3) (2003), 26-38.
31. P. Jenner and C.W. Olanow, Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 (1996), 161-170.
32. J.P. Kapfhammer and M.E. Schwab, Inverse patterns of myelination and GAP-43 expression in the adult CNS: neurite growth inhibitors as regulators of neuronal plasticity, J. Comp. Neurol. 340 (1994), 194-206.
33. M. Marin-Padilla, Ontogenesis of the pyramidal cell of the mammalian neocortex and developmental cytoarchitectonics: A unifying theory, J. Comp. Neurol. 321 (1992), 223-240.
34. M.M. Mesulam, From sensation to cognition, Brain 121 (1998), 1013-1052.
35. V.M. Moceri, W.A. Kukull, I. Emanuel, G. van Belle and E.B. Larson, Early-life risk factors and the development of Alzheimer's disease, Neurology 54 (2000), 415-420.
36. B.M. Morrison, P.R. Hof and J.H. Morrison, Determinants of neuronal vulnerability in neurodegenerative diseases, Ann. Neurol. 44(suppl. 1) (1998), 32-44.
37. R. Nieuwenhuys, The neocortex: an overview of its evolutionary development, structural organization and synaptology, Anat. Embryol. 190 (1994), 307-337.
38. R. Nieuwenhuys, The greater limbic system, the emotional motor system and the brain, Progr. Brain Res. 107 (1996), 551-580.
39. R. Nieuwenhuys, Structure and organization of fiber systems, in: The Central Nervous System of Vertebrates, (Vol. 1), R. Nieuwenhuys, H.J. Ten Donkelaar and C. Nicholson, eds, Springer, Berlin, 1999, pp. 113-157.
40. S.I. Rapoport, Brain evolution and Alzheimer's disease, Rev. Neurol. (Paris) 144 (1988), 79-90.
41. B. Reisberg, A. Pattschull-Furlan, E. Franssen, S.G. Sclan, A. Kluger, L. Dingcong and S.H. Ferris, Dementia of the Alzheimer type recapitulates ontogeny inversely on specific ordinal and temporal parameters, in: Neurodevelopment, Aging and Cognition, I. Kostovic, S. Knezevic, H.M. Wisniewski and G.J. Spillich, eds, Birkhäuser, Boston, 1992, pp. 345-369.
42. B. Reisberg, E.H. Franssen, S.M. Hasan, I. Monteiro, I. Boksay, L.E.M. Souren, S. Kenowsky, S.R. Auer, S. Elahi and A. Kluger, Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes, Eur. Arch. Psychiatry Clin. Neurosci. 249(suppl. 3) (2003), 28-36.
43. R.S. Sohal, Oxidative stress hypothesis of aging, Free Radical Biol. Med. 33 (2002), 573-574.
44. P.A. Szweda, M. Camouse, K.C. Lundberg, T.D. Oberley and L.I. Szweda LI, Aging, lipofuscin formation, and free radical-mediated inhibition of cellular proteolytic systems, Aging Res. Rev. 2 (2003), 383-405.
45. M. Tolnay and A. Probst, Review: tau protein pathology in Alzheimer's disease and related disorders, Neuropathol. Appl. Neurobiol. 25 (1999), 171-187.
46. J.Q. Trojanowski and V.M.Y. Lee, "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders, Ann. N. Y. Acad. Sci. 924 (2000), 62-67.
47. M.S. van der Knaap and J. Valk, Magnetic Resonance of Myelin, Myelination, and Myelin Disorders, (2nd ed.), Springer, Berlin, 1995.
48. M.S. van der Knaap, J. Valk, C.J. Bakker, M. Schooneveld, J.A.J. Faber, J. Willemse and P.H.J.M. Gooskens, Myelination as an expression of the functional maturity of the brain, Dev. Med. Child Neurol 33 (1991), 849-857.
49. P.I. Yakovlev and A.R. Lecours, The myelogenetic cycles of regional maturation of the brain, in: Regional development of the brain in early life, A. Minkowksi, ed., Blackwell, Oxford, 1967, pp. 3-70.
50. K. Zilles, Architecture of the human cortex, in: The Human Nervous System, (2nd ed.), G. Paxinos and J.K. Mai, eds, Elsevier Academic Press, San Diego, London, 2004, pp. 997-1060.